Determination of Soluble Fibrin in Plasma by a Rapid and Quantitative Spectrophotometric Assay

Summary

A rapid, sensitive and quantitative spectrophotometric assay of soluble fibrin in plasma samples has been developed. The method is based on the principle that fibrin stimulates the activation of plasminogen by tissue plasminogen activator (t-PA). A sample containing fibrin is incubated with t-PA, plasminogen and a plasmin-sensitive chromogenic substrate. An increase in absorbance which is dependent on the fibrin concentration in the sample is obtained. In plasma samples an initial lag-phase, due to the presence of alpha₂-antiplasmin is observed. However, the change in A₄₀₅ per square minute during the later part of the reaction was found to be proportional to the fibrin content and to generate linear standard curve intercepts at the origin. The detection limit of bathroxobin-digested fibrinogen added to plasma was about 5 nmol/L. Recovery experiments at 20 and 75 nmol/L levels in plasma samples from healthy individuals were excellent. The “within-run” variation (CV) was determined as 3.7%. The formation of fibrin after addition of minute amounts of thrombin to plasma could be monitored with the method. Plasma from 8 healthy individuals was found to contain about 9.2 ± 1.9 nmol/L fibrin. Plasma samples from 46 patients with a suspected haemostatic disturbance had higher levels of soluble fibrin (53 ± 62 nmol/L). Seven of the 46 samples had concentrations above 150 nmol/L.

Key words

Soluble fibrin - Disseminated intravascular coagulation - Fibrin stimulated plasminogen activation

• References

• 1 Fletcher AP, Alkjaersig N. The use and monitoring of antithrombotic drug therapy. The need for a new approach. Thromb Haemostas 1977; 38: 881-892
• 2 Matthias FR, Reinicke R, Heene DL. Affinity chromatography and quantitation of soluble fibrin from plasma. Thromb Res 1977; 10: 365-384
• 3 Félez J, Plow EF, Wiman B, Collen D. A coagulo-radioimmunome-tric assay for the quantitation of fibrin monomer in human plasma. Principles and development of the method. Thromb Res 1979; 16: 175-189
• 4 Nossel HL, Younger LR, Wilner GD. et al. Radioimmunoassay of human fibrinopeptide A. Proc Natl Acad Sci 1971; 68: 2350-2353
• 5 Godal HL, Abildgaard U, Kierulf P. Ethanol gleation and fibrin monomers in plasma. Scand J Haematol Suppl 1971; 13: 189-191
• 6 Niewiarowski S, Gurevich V. Laboratory identification of intravascu-lar coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. J Lab Clin Med 1971; 77: 665-676
• 7 Kisker CT, Plummer G, Taylor B. A method for measurement of fibrin monomer with the use of an immune precipitate of fibrinogen. J Lab Clin Med 1977; 89: 653-658
• 8 Bilezikian SB, Nossel HL, Butler Jr VP. et al. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes. J Clin Invest 1975; 56: 438-445
• 9 Nossel HL, Yudelman I, Canfield RE. et al. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43-53
• 10 Rånby M. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta 1982; 704: 461-469
• 11 Wallén P, Pohl G, Bergsdorf N, Råndy M, Jörnvall H. Purification and structural characterization of a melanoma cell plasminogen activator. Eur J Biochem 1983; 132: 681-686
• 12 Deutsch DG, Mertz ET. Plasminogen purification of from human plasma by affinity chromatography. Science 1980; 170: 1095-1096
• 13 Wiman B. Human alpha₂-antiplasmin. Methods in enzymol 1982; 80: 394-408
• 14 Plow EF, Edgington TS. A cleavage-associated neoantigenic marker for a gamma-chain site in the NH₂-terminal aspect of the fibrinogen molecule. J Biol Chem 1975; 250: 3386-3392
• 15 Vermylen C, de Vreker RA, Verstraete M. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). Clin Chim Acta 1961; 8: 418-424
• 16 Råndy M, Norrman B, Wallén P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982; 27: 743-749
• 17 Wiman B, Mellbring G, Råndy M. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay. Clin Chim Acta 1983; 127: 279-288
• 18 Chmielewska J, Råndy M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436
• 19 Wiman B, Chmielewska J. A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance. Scand J Clin Lab Invest 1985; 45 (Suppl. 177) 43-47
• 20 Radcliffe R, Heinze T. Stimulation of tissue plasminogen activator by denaturated proteins and fibrin clots: a possible additional role for plasminogen activator?. Arch Biochem Biophys 1981; 211: 750-761